Interestingly, one gain of function oncogenic mutation in the MAP2K1 gene could be found in a CCA cell line (p.K57T, negative regulatory domain) and in a case of gallbladder adenocarcinoma (p.G128D, kinase domain). This evidence concerns the gene MAP2K1 and gallbladder adenocarcinoma.